COVID-19 | Diagnostics | NIH
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
CureVac focuses on development of mRNA-based coronavirus vaccine to protect people worldwide
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
CureVac’s optimized mRNA platform provided positive pre-clinical results at low dose for Coronavirus vaccine candidate
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
Roche announced FDA Emergency Use Authorization and availablabilityof cobas SARS-CoV-2 detection test
On Mar. 13, 2020, Roche announced the FDA has issued an Emergency Use Authorization for the cobasﾮ SARS-CoV-2…
FDA issued Emergency Use Authorization to Thermo Fisher Scientific for diagnostic test for COVID-19
On Mar. 13, 2020, Thermo Fisher Scientific announced the FDA has issued an emergency use authorization (EUA) for…
Disease | Therapeutics | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, the Federal Government, along with State and local governments, announced preventive and proactive measures…
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Large scale COVID-19 testing of general population begun in Iceland
On Mar. 13, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
Leading veterinary diagnostic company saw no COVID-19 cases in pets early in Pandemic
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
BioReference Laboratories offers testing for Coronavirus disease 2019 (COVID-19)
On Mar. 13, 2020, BioReference Laboratories, an OPKO company, announced it had begun accepting specimens for testing of…
Luminex provided update on SARS-CoV-2 validation testing efforts
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
AbCellera and Eli Lilly to co-develop antibody therapies for treatment of COVID-19
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
Innovation Pharma announced testing procedures of Brilacidin against Coronavirus
On Mar. 12, 2020, Innovation Pharma announced research procedures that one of the 12 Regional Biocontainment Labs (RBLs)…
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 12, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
Mayo Clinic developed test to detect COVID-19 infection
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
Chembio and LumiraDx announced COVID-19 strategic partnership
On Mar. 12, 2020, Chembio Diagnostics announced it has entered into a worldwide strategic partnership with LumiraDx Limited…
Qatar reported one confirmed case of Middle East Respiratory Syndrome Coronavirus infection
On May 12, 2022, the National IHR Focal Point for Qatar reported two laboratory-confirmed cases of Middle East…
Pluristem and Charit’ University of Medicine Berlin joinly target potential treatment for respiratory and inflammatory Intratissue complications caused by COVID-19
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
World Health Organization declared the Coronavirus outbreak a global pandemic
On Mar. 11 2020, the World Health Organization declared the Coronavirus outbreak a global pandemic. To-date, of the…
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
La Jolla Institute for Immunology identified potential targets for immune responses to novel coronavirus
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
CaroGen and Yale scientists joined to develop a COVID-19 vaccine
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
U.S. Regional Biocontainment Lab to begin testing of Brilacidin against Coronavirus (COVID-19)
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
Biotechnology | HIV | NIH
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
Humanigen’s lenzilumab a potential therapeutic for lung damage arising from Coronavirus
On Mar. 9, 2020, Humanigen announced that it was actively exploring clinical stage strategies and partnerships to evaluate…
Innovation Pharma Brilacidin received by US Regional Biocontainment Lab for testing against COVID-19
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
Ampligen to be tested by Japan’s National Institute of Infectious Diseases as potential treatment for SARS-CoV-2
On Mar. 8, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
UTSW researchers and international collaborators found human protein that potently inhibits coronavirus
On Mar. 8, 2020, an international team of investigators reported finding a protein produced by the human immune…